MedPath

Sodium Nitroprusside

Sodium Nitroprusside InjectionRx only

Approved
Approval ID

2122b9c1-0af4-493b-82cc-63eee02f987f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 14, 2023

Manufacturers
FDA

Somerset Therapeutics, LLC

DUNS: 079947873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Nitroprusside

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70069-261
Application NumberANDA210882
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Nitroprusside
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 14, 2023
FDA Product Classification

INGREDIENTS (2)

SODIUM NITROPRUSSIDEActive
Quantity: 25 mg in 1 mL
Code: EAO03PE1TC
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Nitroprusside - FDA Drug Approval Details